ArticleJournal for immunotherapy of cancer2026
Dysregulated expression of the tumor suppressor p14ARF in cancer provides an effective target for TCR-T cell therapeutics.
Thomas M Schmitt et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.